RVAC Medicines

company

About

RVAC Medicines is a mRNA platform company engaged in the research and development of innovative products such as vaccines for diseases.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$140M
Industries
Biotechnology,Medical,Product Research
Founded date
Jan 1, 2021
Number Of Employee
101 - 250
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$140M
RVAC Medicines has raised a total of $140M in funding over 2 rounds. Their latest funding was raised on Apr 26, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 26, 2022 Series B $140M 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
RVAC Medicines has made 1 investments. Their most recent investment was on Jul 4, 2021, when Trukkr raised $600K.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 4, 2021 Trukkr
Seed $600K Financial Services

Investors

Number of Lead Investors
Number of Investors
1
RVAC Medicines is funded by 1 investors. Pavilion Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Pavilion Capital Series B